The disruption of the vaginal and urinary microbiota ecosystem contributes to the overgrowth of pathogens which can cause infections, including urinary tract infections, bacterial vaginosis, and others1,2,3,4.
GYNTIMA (or AB-INTIMUS) oral restores vaginal microbiota after an infection, to prevent relapses and support antibiotic treatment. Ensures a healthy, balanced vaginal flora. 30 capsules for a preventive treatment against candidiasis and bacterial vaginosis
GYNTIMA (also known as AB-INTIMUS) restores vaginal microbiota after an infection, to prevent relapses and support antibiotic treatment. Ensures a healthy, balanced vaginal flora. A medical device that contains 7 vaginal tablets for a complete, 14-day treatment.
AB-CYSCARE naturally protects the urinary tract from infections, and can be used as a treatment together with antibiotics
1. Meštrović, T. et al. The Role of Gut, Vaginal, and Urinary Microbiome in Urinary Tract Infections: From Bench to Bedside. Diagnostics 11, 7 (2020). 2. Stapleton, A. E. The Vaginal Microbiota and Urinary Tract Infection. Microbiol. Spectr. 4, (2016). 3. Whiteside, S. A., Razvi, H., Dave, S., Reid, G. & Burton, J. P. The microbiome of the urinary tract – A role beyond infection. Nature Reviews Urology vol. 12 81–90 (2015). 4. Chee, W. J. Y., Chew, S. Y. & Than, L. T. L. Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health. Microbial Cell Factories vol. 19 1–24 (2020). Curr. Microbiol. 74, 987–995 (2017).
AB-BIOTICS SA
Av. Torre Blanca 57
ESADE Creapolis Building
Sant Cugat del Valles
08172 Spain
(+34) 935 803 876
Kaneka Americas Holding, Inc.
Probiotics Division
7979 Gateway Boulevard
Newark (California)
94560 United States
AB-BIOTICS Pte Ltd
10 Anson Road #12-14
International Plaza
Singapore 079903
